GlycoMimetics Announces Change to Virtual Meeting Format for 2020 Annual Meeting of Shareholders
May 08 2020 - 8:30AM
Business Wire
GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that its 2020
Annual Meeting of Shareholders (the “Annual Meeting”) will be held
virtually instead of in person. Due to the ongoing public health
impact of the COVID-19 pandemic and to support the health and
well-being of the Company’s stockholders, employees and their
families, the Company will hold the Annual Meeting via live audio
webcast rather than as an in-person meeting. The virtual Annual
Meeting is expected to provide stockholders with the same rights
and opportunities to participate as they would have at an in-person
meeting. As previously announced, the Annual Meeting will be held
on Friday, May 22, 2020 at 9:00 a.m. EDT.
As described in the Company’s proxy materials previously
distributed for the Annual Meeting, stockholders at the close of
business on April 9, 2020, the record date, are entitled to
participate in and vote at the Annual Meeting. Online access to the
Annual Meeting will begin at 8:45 a.m. EDT. Stockholders will not
be able to attend the Annual Meeting in person. To participate in
and/or vote at the virtual Annual Meeting, stockholders should
utilize the special website address at
www.virtualshareholdermeeting.com/GLYC2020. Stockholders
must enter the 16-digit control number found on their proxy card.
Stockholders may still vote prior to the Annual Meeting by
Internet, telephone or by mail per the instructions on their proxy
card. The webcast of the Annual Meeting will be archived for one
year after the date of the Annual Meeting at
www.virtualshareholdermeeting/GLYC2020. Instructions on how to
connect to the Annual Meeting and participate via the Internet,
including how to demonstrate proof of stock ownership, are posted
at www.virtualshareholdermeeting.com/GLYC2020.
Asking Questions
If you are attending the Annual Meeting as stockholder of record
or beneficial owner, questions can be submitted by accessing the
meeting center at
www.virtualshareholdermeeting.com/GLYC2020, entering your
16-digit control number. Instructions on how to participate in the
Annual Meeting are posted at
www.virtualshareholdermeeting.com/GLYC2020.
Voting Shares
Stockholders of record and beneficial owners will be able to
vote their shares electronically during the Annual Meeting by using
the 16-digit control number. Instructions on how to vote while
participating in the Annual Meeting live via the Internet are
posted at www.virtualshareholdermeeting.com/GLYC2020.
Whether or not stockholders plan to virtually attend the Annual
Meeting, the Company urges them to vote and submit their proxy in
advance of the Annual Meeting by one of the methods described in
the proxy materials for the Annual Meeting.
The proxy materials, including the proxy card and Notice of
Internet Availability of Proxy Materials, previously distributed
along with the definitive proxy statement will not be updated to
reflect the change in location and may continue to be used to vote
shares in connection with the Annual Meeting.
Attending the Annual Meeting as a Guest
Guests may enter the Annual Meeting in “listen-only” mode by
entering the Annual Meeting at
www.virtualshareholdermeeting.com/GLYC2020 and entering the
information requested in the “Guest Login” section. Guests will not
have the ability to vote or ask questions during the Annual
Meeting.
List of Stockholders
A list of stockholders entitled to vote at the Annual Meeting
will be available for examination for any purpose germane to the
Annual Meeting during normal business hours for ten days prior to
the Annual Meeting at our corporate headquarters. To the extent
office access is impracticable due to the recent COVID-19 pandemic,
you may email us at ir@glycomimetics.com for alternative
arrangements. The stockholder list will also be available during
the Annual Meeting at
www.virtualshareholdermeeting.com/GLYC2020. Instructions on
how stockholders of record can view the stockholder list during the
Annual Meeting are posted at
www.virtualshareholdermeeting.com/GLYC2020.
Your vote is important to us. Whether or not you plan to
participate in the live audio webcast of our annual meeting, we
hope you will vote as soon as possible. Voting now at
www.proxyvote.com will ensure your representation at the Annual
Meeting.
The proxy statement for the Annual Meeting and the Company’s
2019 Annual Report are available at
http://materials.proxyvote.com/38000Q. These materials also
are available on the Company’s website at www.glycomimetics.com
under “Investors” and then “Financials and Filings.”
Our first priority is always the health and safety of our
stockholders and employees. Our thoughts are with those already
impacted by COVID-19 and our gratitude is with the many on the
front lines of confronting this public health crisis. We look
forward to your participation at our virtual Annual Meeting.
About GlycoMimetics, Inc.
GlycoMimetics is a clinical-stage biotechnology company focused
on the discovery and development of novel glycomimetic drugs to
address unmet medical needs resulting from diseases in which
carbohydrate biology plays a key role. GlycoMimetics’ wholly-owned
drug candidate, uproleselan, an E-selectin antagonist, was
evaluated in a Phase 1/2 clinical trial as a potential treatment
for acute myeloid leukemia (AML) and is being evaluated across a
range of patient populations including a Company-sponsored Phase 3
trial in relapsed/refractory AML. GlycoMimetics has also completed
a Phase 1 clinical trial with another wholly-owned drug candidate,
GMI-1359, a combined CXCR4 and E-selectin antagonist. GlycoMimetics
is located in Rockville, MD in the BioHealth Capital Region. Learn
more at www.glycomimetics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200508005232/en/
Investor Contact: Shari Annes Phone: 650-888-0902 Email:
sannes@annesassociates.com
Media Contact: Jamie Lacey-Moreira Phone: 410-299-3310 Email:
jamielacey@presscommpr.com
GlycoMimetics (NASDAQ:GLYC)
Historical Stock Chart
From Mar 2024 to Apr 2024
GlycoMimetics (NASDAQ:GLYC)
Historical Stock Chart
From Apr 2023 to Apr 2024